FidoCure Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 28

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 20

FidoCure General Information

Description

Provider of personalized medicine services intended to offer advanced cancer care beyond chemo and radiation for dogs. The company collects tissue samples for deoxyribonucleic acid (DNA) sequencing and creates a personalized deoxyribonucleic acid (DNA) report that helps identify genetic mutations that may affect treatment and then suggest targeted therapy for precisely attacking the cancer cells, enabling pet owners and veterinarians to eradicate canine cancer, thereby improving the quality of life for clients' canine friends.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Corporate Office
  • 530 Lytton Avenue
  • 2nd Floor
  • Palo Alto, CA 94301
  • United States
+1 (415) 000-0000

FidoCure Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FidoCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 01-Mar-2022 000.00 Completed Generating Revenue
8. Later Stage VC (Series A) 31-Mar-2021 000.00 000.00 000.00 Completed Generating Revenue
7. Seed Round 23-Jan-2019 000 00.000 000.00 Completed Generating Revenue
6. Seed Round 31-Oct-2018 00.000 Completed Generating Revenue
5. Secondary Transaction - Private 17-May-2018 00.000 Completed Generating Revenue
4. Debt - General 00.000 Completed Generating Revenue
3. Accelerator/Incubator 20-Mar-2018 00000 00.000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 16-Jun-2017 $50K $1.25M Completed Generating Revenue
1. Seed Round 01-Mar-2017 $1.25M $1.25M Completed Generating Revenue
To view FidoCure’s complete valuation and funding history, request access »

FidoCure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Seed 000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view FidoCure’s complete cap table history, request access »

FidoCure Patents

FidoCure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020326612-A1 Treatment of canine cancers Pending 02-Aug-2019 000000000
CA-3149796-A1 Anti-cancer agents for the treatment of canine cancers Pending 02-Aug-2019 000000000
US-20220354951-A1 Treatment of canine cancers Pending 02-Aug-2019 000000000
EP-4007585-A1 Treatment of canine cancers Pending 02-Aug-2019 000000000
US-20230355767-A1 Treatment of canine cancers Pending 02-Aug-2019 A61K41/00
To view FidoCure’s complete patent history, request access »

FidoCure Executive Team (11)

Name Title Board Seat Contact Info
Christina Lopes Ph.D Co-Founder, Chief Executive Officer & Board Member
Benjamin Lewis Co-Founder & Chief Strategy Officer
Gerald Post Ph.D Chief Medical Officer & Chief Veterinary Officer
Chase Schwalbach Chief Product Officer
Ravi Tolwani Ph.D Member of Medical and Veterinary Advisory Board
You’re viewing 5 of 11 executive team members. Get the full list »

FidoCure Board Members (2)

Name Representing Role Since
Christina Lopes Ph.D FidoCure Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

FidoCure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FidoCure Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bossa Invest Venture Capital Minority 000 0000 000000 0
Global Brain Venture Capital Minority 000 0000 000000 0
Mana Ventures Venture Capital Minority 000 0000 000000 0
Borealis Ventures Venture Capital Minority 000 0000 000000 0
Civilization Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 20 investors. Get the full list »

FidoCure FAQs

  • When was FidoCure founded?

    FidoCure was founded in 2016.

  • Who is the founder of FidoCure?

    Christina Lopes Ph.D, Benjamin Lewis, Franca Angeli Ph.D, and Jason Zuniga are the founders of FidoCure.

  • Who is the CEO of FidoCure?

    Christina Lopes Ph.D is the CEO of FidoCure.

  • Where is FidoCure headquartered?

    FidoCure is headquartered in Palo Alto, CA.

  • What is the size of FidoCure?

    FidoCure has 28 total employees.

  • What industry is FidoCure in?

    FidoCure’s primary industry is Other Healthcare Services.

  • Is FidoCure a private or public company?

    FidoCure is a Private company.

  • What is FidoCure’s current revenue?

    The current revenue for FidoCure is 00000.

  • How much funding has FidoCure raised over time?

    FidoCure has raised $17.1M.

  • Who are FidoCure’s investors?

    Bossa Invest, Global Brain, Mana Ventures, Borealis Ventures, and Civilization Ventures are 5 of 20 investors who have invested in FidoCure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »